To investigate the molecular mechanisms controlling MED1 expression in breast cancer, we used three different microRNA target prediction programs (Pictar, TargetScan and miRanda) to screen for miRNAs that target MED1 [39,40]. Here, MED1 is linked to breast carcinoma.